Shopping Cart
- Remove All
Your shopping cart is currently empty
AZD5462 is a potent orally available relaxin receptor RXFP1 agonist for the study of heart failure and cancer.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $373 | In Stock | |
| 5 mg | $895 | In Stock | |
| 10 mg | $1,270 | In Stock | |
| 25 mg | $1,980 | In Stock | |
| 50 mg | $2,780 | In Stock | |
| 100 mg | $3,520 | In Stock |
| Description | AZD5462 is a potent orally available relaxin receptor RXFP1 agonist for the study of heart failure and cancer. |
| Targets&IC50 | cAMP:17 nM (EC50s), cGMP:50 nM (EC50s) |
| In vitro | AZD5462 (example 1) exhibits stimulatory activity on cAMP or cGMP production with EC50s of 17 nM and 50 nM, respectively[1]. Binding to human plasma proteins with a fraction unbound (free) rate of 4.3%, AZD5462 demonstrates stability with Clint values of 23 μL/min/mg (human liver microsomal), 4.8 μL/min/10^6 cells (human hepatocyte), and 11 μL/min/10^6 cells (rat hepatocyte)[1]. AZD5462 enhances the phosphorylation of ERK with an EC50 value of 6.3 nM[1]. |
| Molecular Weight | 544.65 |
| Formula | C30H41FN2O6 |
| Cas No. | 2787501-83-9 |
| Smiles | C(NCC1(C)CCC1)(=O)[C@@H]2[C@H](NC(=O)C3=C(OC)C=C(F)C(O[C@H]4CC[C@](C(O)=O)(C)CC4)=C3)[C@@]5(C[C@]2(CC5)[H])[H] |
| Color | White |
| Appearance | Solid |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50 mg/mL (91.8 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (3.67 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.